Press Releases
-
Takeda Launches the First and Only Orexin Medicine ORZEYFUL for Narcolepsy Type 1 in the US
Takeda has launched ORZEYFUL in the US as the first approved orexin agonist for adults with narcolepsy type 1. The treatment targets underlying orexin deficiency and offers a new approach to managing multiple disease symptoms.
Nov 12, 2026
-
Phenomix Sciences and Mayo Clinic Present New Research on Predicting GLP-1 Response and Weight Regain at ObesityWeek® 2026
Studies presented at ObesityWeek 2026, including two further validating the MyPhenome® test, strengthen the evidence base for precision obesity medicine.
Nov 12, 2026
-
START Expands its Global Early Phase Cancer Site Network into Italy Through Strategic Partnership with Istituti Fisioterapici Ospitalieri
The new START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for patients in a major European oncology market.
Nov 2, 2026
-
PharmaForceIQ Launches Share of Answer Module to Evaluate and Act on AI Visibility
Share of Answer Connects AI visibility audits with prioritized actions to help biopharma teams improve how brands and disease education content are represented in AI-generated answers
Nov 1, 2026
-
Numbers Show More Biotech Sponsors Turn to Kivo to Keep TMFs and Assets Diligence-Ready
In a more selective funding market, drug development teams are keeping their trial and regulatory records organized for investors, partners, and acquirers
Nov 5, 2026
-
PumasAI Unveils Pumas 2.9 with Advanced Scientific Modeling and Simulation for Better Clinical Pharmacology and Pharmacometrics Performance
Latest release delivers expanded modeling capabilities, improved computational performance, and greater reproducibility for advanced pharmacometric workflows
Nov 5, 2026
-
Ametris and Biosency announce partnership to expand Ametris' respiratory digital measures suite with objective COPD exacerbation endpoints
Ametris and Biosency announce partnership for objective COPD exacerbation endpoints
Nov 8, 2026
-
One Year After Launch, Plasmidsaurus RNA-Seq Challenges RT-qPCR as the Standard for Routine Gene Expression Analysis
One year after launching its ultrafast RNA-Seq service, Plasmidsaurus has reached more than 9,000 researchers across 1,000+ institutions, processing hundreds of thousands of samples to date.
Nov 9, 2026
-
New global Mouth-to-Body Health Institute aims to turn oral systemic science into better prevention and care
The Sunstar Mouth-to-Body Health™ Institute aims to become an international leader in oral-systemic health by bringing together researchers, clinicians and scientific leaders from dentistry, medicine, microbiology, immunology, nutrition, behavioural science and public health to unlock the role of the mouth’s influence on health throughout the body.
Nov 9, 2026
-
Lilly Brings FDA-Approved GLP-1 Treatments to Hims & Hers Digital Platform
Lilly and Hims & Hers have partnered to expand access to FDA-approved Zepbound and Foundayo through telehealth. Monthly self-pay prices start at $299 for Zepbound and $149 for Foundayo.
Nov 9, 2026
-
Yourgene Health Insight DPYD Assay Secures TGA Regulatory Approval in Australia
• Assay enables comprehensive pharmacogenetic testing to support safer, personalised chemotherapy treatment for cancer patients • Southern Cross Diagnostics to supply IVD assay to clinical diagnostics laboratories in Australia
Nov 11, 2026
-
Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptional Cost Efficiency
Biognosys Group, a fully owned affiliate of Bruker Corporation, today announced the launch of Industrialized Discovery.
Nov 9, 2026
-
CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist
CluePoints, a leading provider of Risk-Based Quality Management (RBQM) and clinical data quality oversight software, has been named a finalist in the Data Analytics/Business Intelligence category at the 2026 Fierce Life Sciences Innovation Awards.
Oct 28, 2026
-
Sciensus Appoints James Tugendhat OBE as Chief Executive Officer
Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing more than 20 years of leadership experience across healthcare and complex service organisations.
Oct 28, 2026
-
Samplix Secures Backing to Accelerate Xdrop’s Commercial Expansion in Antibody Discovery
Samplix today announced financing led by WLanholding GmbH to expand commercial adoption of Xdrop, its single-cell screening platform that helps researchers identify and recover cells producing antibodies with the desired biological function.
Oct 26, 2026
-
Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility
Ceryx Medical and King’s College London today announced that the first implantable device has been manufactured at MAISI, the national facility for the Manufacture of Active Implants and Surgical Instruments.
Oct 21, 2026
-
CPHI targets Spain’s €38bn pharma market with new Barcelona event
Oct 21, 2026
-
Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research
Research at Brigham and Women’s Hospital and Ochsner Health demonstrates how continuous physiologic data helps translate clinical research into more actionable patient care - Continuous monitoring with wearables addresses a key challenge of translational medicine, allowing for uninterrupted data capture that can detect physiologic changes in a patient’s condition. - Vivalink’s Clinical Intelligence Platform enables automated monitoring, transmission and processing of patient data to help derive clinical insights. - Observing patients in their everyday settings gives researchers insights to their conditions outside of controlled settings, like in the hospital or at clinical trial sites.
Oct 21, 2026
-
eClinical Solutions Expands Executive Leadership with Three Strategic C-Suite Appointments
eClinical Solutions announced three new leadership appointments, including Chief Product Officer (Nathan Johnson), Chief People Officer (Brian Testa), and Chief Financial Officer (Jessica Allen).
Oct 21, 2026
-
Advanced Clinical appoints John Cargill as Chief Commercial Officer to accelerate global growth
Oct 21, 2026


